Japan In-Vitro Diagnostics Market is predicted to reach USD 5.26 Billion by 2030

According to the study by Next Move Strategy Consulting, the Japan In-Vitro Diagnostics Market size is predicted to reach USD 5.26 billion, at a CAGR of 5.4% by 2030.

Request a FREE Sample: https://www.nextmsc.com/japan-in-vitro-diagnostics-market/request-sample

The rise in aging population boosts the demand for advanced diagnostics techniques such as in-vitro diagnostics.

The continuous introduction of new products by key players such as Sysmex Corporation enhances competition and innovation within the in-vitro diagnostics market and further driving the market growth in Japan.

The promising players operating in the Japan in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.